Sign in

CIK 0001540159 · Non-accelerated filer<br>Smaller reporting company

Edesa Biotech, Inc.

Sign in to watch
Ticker
EDSA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Sep 30
Incorporated
British Columbia, Canada
Entity type
operating
Phone
(905) 475-1234
Business address
C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
Former names
Stellar Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-05-29 Marshall Patrick Director Grant or award +11,000 52,666
2025-05-29 Olson Charles V Director Grant or award +11,000 11,000
2025-05-29 Sistilli Carlo Director Grant or award +20,001 30,417
2025-05-29 Nijhawan Pardeep Chief Executive Officer Grant or award +263,200 442,123
2025-05-29 MacDonald Sean Arthur Director Grant or award +20,001 22,054
2025-05-29 Chypyha Joan Director Grant or award +11,000 11,029
2025-05-29 Brooks Michael J President Grant or award +207,201 224,870
2025-05-29 Liu Da David Director Grant or award +5,501 5,501
2025-05-02 Nijhawan Pardeep Chief Executive Officer Grant or award +6,392 178,923
2025-04-01 Nijhawan Pardeep Chief Executive Officer Grant or award +5,784 172,531
2025-03-03 Nijhawan Pardeep Chief Executive Officer Grant or award +6,339 166,747
2025-02-12 Sistilli Carlo Director Grant or award +10,416 $1.92 $20K 10,416
2025-02-12 Nijhawan Pardeep Chief Executive Officer Grant or award · Series B-1 Convertible Preferred Shares +100 100
2025-02-12 Marshall Patrick Director Grant or award +41,666 $1.92 $80K 41,666
2025-02-03 Nijhawan Pardeep Chief Executive Officer Grant or award +8,264 160,408
2025-01-06 Nijhawan Pardeep Chief Executive Officer Grant or award +8,476 152,144
2024-12-02 Nijhawan Pardeep Chief Executive Officer Grant or award +6,420 143,668
2024-11-12 Nijhawan Pardeep Chief Executive Officer Grant or award +4,630 137,248
2024-10-30 Nijhawan Pardeep Chief Executive Officer Grant or award · Series A-1 Convertible Preferred Shares +150 150
2024-10-30 Nijhawan Pardeep Chief Executive Officer Grant or award · Warrants (right to buy) +326,560 326,560

Page 3 of 15 · 284 trades